Author:
Li Li,Wang Huiyu,Wang Haiping,Li Lijun,Wang Pan,Wang Xiaobing,Liu Quanhong
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Bellnier, D. A. et al. Population Pharmacokinetics of the Photodynamic Therapy Agent 2-[1-Hexyloxyethyl]-2-devinyl Pyropheophorbide-a in Cancer Patients. Cancer Res 63, 1806–1813 (2003).
2. Tanaka, M. et al. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin). Oncotarget 7, 47242–47251, doi: 10.18632/oncotarge. 9725 (2016).
3. Shi, J. et al. Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer. Theranostics 1, 363–370 (2011).
4. Henderson, B. W. & Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol 55, 145–157 (1992).
5. Kaspler, P. A. et al. ruthenium (ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy. Photochem. Photobiol. Sci 15, 481–495 (2016).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献